CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$999,994. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-06 | Newell Joe Chief Tech. Operations Officer | Grant or award | +25,000 | 32,500 | ||
| 2018-02-06 | Newell Joe Chief Tech. Operations Officer | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-02-06 | Soffer Gad EVP & Chief Strategy Officer | Grant or award | +17,500 | 273,736 | ||
| 2018-02-06 | Soffer Gad EVP & Chief Strategy Officer | Shares withheld for taxes | −3,987 | $35.80 | $143K | 269,749 |
| 2018-02-06 | Soffer Gad EVP & Chief Strategy Officer | Grant or award · Employee Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2018-02-06 | Porter Derrell SVP, Head of Global Commercial | Grant or award | +12,500 | 14,044 | ||
| 2018-02-06 | Porter Derrell SVP, Head of Global Commercial | Grant or award · Employee Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-02-06 | Clark Mitchall G. EVP & Chief R & QA Officer | Grant or award | +25,000 | 188,054 | ||
| 2018-02-06 | Clark Mitchall G. EVP & Chief R & QA Officer | Shares withheld for taxes | −4,437 | $35.80 | $159K | 183,617 |
| 2018-02-06 | Clark Mitchall G. EVP & Chief R & QA Officer | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-02-06 | MCGRATH JOHN EVP & Chief Financial Officer | Grant or award | +25,000 | 114,654 | ||
| 2018-02-06 | MCGRATH JOHN EVP & Chief Financial Officer | Shares withheld for taxes | −4,279 | $35.80 | $153K | 110,375 |
| 2018-02-06 | MCGRATH JOHN EVP & Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-02-06 | Ciechanover Isaac E. Chief Executive Officer | Grant or award | +65,000 | 808,675 | ||
| 2018-02-06 | Ciechanover Isaac E. Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +130,000 | 130,000 | ||
| 2018-01-26 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,100 | $35.46 | $39K | 299,878 |
| 2018-01-26 | Ciechanover Isaac E. Chief Executive Officer | Sale | −6,100 | $36.54 | $223K | 293,778 |
| 2018-01-26 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,100 | $36.98 | $78K | 291,678 |
| 2018-01-25 | Ciechanover Isaac E. Chief Executive Officer | Sale | −1,400 | $33.22 | $47K | 309,578 |
| 2018-01-25 | Ciechanover Isaac E. Chief Executive Officer | Sale | −8,400 | $34.23 | $288K | 301,178 |
Page 37 of 44 · 867 trades